- Report
- October 2023
- 146 Pages
Global
From €3777EUR$4,150USD£3,238GBP
- Report
- April 2024
- 80 Pages
Argentina
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Brazil
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
China
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
France
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Germany
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
India
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Ireland
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Japan
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Poland
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Russia
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1365EUR$1,500USD£1,170GBP
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2024
- 80 Pages
Vietnam
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
Saudi Arabia
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
India
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2022
- 100 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- July 2022
- 84 Pages
North America
From €1365EUR$1,500USD£1,170GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more